[Federal Register Volume 75, Number 162 (Monday, August 23, 2010)]
[Pages 51830-51831]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-20872]



National Institutes of Health

National Cancer Institute's Best Practices for Biospecimen 

AGENCY: National Institutes of Health (NIH), National Cancer Institute 

ACTION: Notice with request for comment.


SUMMARY: As part of the commitment to maintaining current and 
scientifically accurate best practices, the National Cancer Institute 
(NCI) is seeking public comment on a revised version of the NCI Best 
Practices for Biospecimen Resources. This revised version of the NCI 
Best Practices is intended to both respond to comments received from 
the biospecimen resource community and provide more current and 
detailed recommendations related to biospecimen and data quality. Major 
revisions include the addition of new sections on Biospecimen Resource 
Management and Operations and Conflict of Interest, expansion of 
recommendations related to Custodianship and Informed Consent based on 
NCI workshops, addition of current references throughout the document 
and harmonization with current federal guidance documents and 
recommendations from international biospecimen organizations.

DATES: Effective Date: The updated NCI Best Practices for Biospecimen 
Resources are open for public comment for a period of 30 days. Comments 
must be received by September 22, 2010 in order to ensure 
consideration. After the public comment period has closed, the comments 
received by NCI will be considered in a timely manner by the NCI Office 
of Biorepositories and Biospecimen Research. Subsequently, appropriate 
changes will be made on the Best Practices Web site http://biospecimens.cancer.gov/bestpractices/.

ADDRESSES: Comments submitted via e-mail should use 
[email protected] and enter ``NCI Best Practices'' in the subject 
line. While NCI prefers that comments be sent by email, NCI will accept 
written comments. Written comments may be sent to: NCI/OBRR, NIH, 11400 
Rockville Pike, Rockwall I Building, Bethesda, MD 20892, Attn: Dr. 
Nicole Lockhart.

FOR FURTHER INFORMATION CONTACT: Implementation assistance and 
inquiries should be directed to senior staff of the relevant NCI 
Extramural and Intramural Program offices.

SUPPLEMENTARY INFORMATION: The NCI Best Practices for Biospecimen 

[[Page 51831]]

may be found online at http://biospecimens.cancer.gov/bestpractices/.

    Dated: August 12, 2010.
Douglas R. Lowy,
Deputy Director, National Cancer Institute, National Institutes of 
[FR Doc. 2010-20872 Filed 8-20-10; 8:45 am]